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gene:cs,	 Sam	had	 gene:c	 tes:ng	 and	 an	 ultrasound	performed	 at	 the	 age	 of	 18	 to	





her	 renal	ultrasound.	Sam	began	at	home	dialysis	and	was	placed	on	 the	 the	kidney	
transplant	list.	Sam	was	also	monitored	for	other	complica:ons	such	as	hypertension	
and	cardiac	disease,	she	had	frequent	 	visits	to	her	PCP	and	nephrologist	to	monitor	















	 Autosomal	 dominant	 polycys:c	 kidney	 disease	 (ADPKD)	 and	 autosomal	 recessive	
kidney	 disease	 (ARPKD)	 are	 two	 forms	 of	 polycys:c	 kidney	 disease	 (PKD)	 	 and	 are	
leading	causes	of	end	stage	renal	disease	(ESRD)	(Silverman,	2015).	PKD	can	affect	both	







	 	 	 	 	This	author	currently	works	at	Riverside	Methodist	hospital	on	a	stroke	unit,	where	
PKD	is	an	uncommon	diagnosis.	Recently	a	close	family	friend	received	the	diagnosis	of	
PKD	 and	 had	 to	 undergo	 a	 kidney	 transplant.	With	 this	 friend’s	 diagnosis	 and	 lack	 of	
exposure	 to	 pa:ents	with	 PKD,	 this	 author	 chose	 PKD	 to	 become	more	 familiar,	 gain	
knowledge	and	be_er	care	for	pa:ents	with	PKD.		 Nursing	Implica6ons	
• Obtain	a	complete	medical	history	and	full	body	assessment	
• Encourage	 low-salt	 diet,	 high	water	 intake,	 and	 exercise	 (Tran	 et	 al.,	
2017).	
• Monitor	 blood	 pressure	 and	 provide	 medica:ons	 like	 ACE	 inhibitors	
for	blood	pressure	management	(Tran	et	al.,	2017).	






• The	 gene	 products,	 polycys:n-1	 and	 polycys:n-2,	 encoded	 on	 the	 genes	 PKD-1	 and	 PKD-2,	 regulate	
growth	and	mechanosensory	ac:ons	in	the	renal	tubular	cilia	(Po_s	&	Mousa,	2017).		
• Muta:ons	of	gene	PKD-1	occur	on	chromosome	16	and	PKD-2	on	chromosome	4	(Silverman,	2015).	








of	 the	disease.	Gene:c	counseling	 for	 families	with	PKD	can	help	 iden:fy	and	prepare	 for	 the	
progression	 and	 complica:ons	 PKD	 entails.	 Medica:ons,	 renal	 	 replacement	 therapies,	 and	
kidney	transplants	help	slow	disease	progression	and	provide	disease	treatment,	though	no	cure	
currently	 exists.	 Throughout	 these	 treaments	 it	 is	 important	 for	 health	 care	 provides	 to	 be	
suppor:ve	and	encouragement	to	all	PKD	pa:ents.		
PKD		
Bukanov,	N.O.	(2008,	March).	[Digital	image].	Retrieved	July	25,	2019,	from																		
									h_ps://images.app.goo.gl/Qoqppmw5AK8hvGYdA	
[Shu_erstock	Inc.]	(n.d).	Retrieved	July	25,	2019,	from	h_ps://images.app.goo.gl/tEL99sNVUByg4U7P7	
Büscher,	R.,	Büscher,	A.,	Weber,	S.,			Mohr,	J.,	Hegen,	B.,	Vester,	
U.,	&	Hoyer,	P.	(2014).	Clinical	manifesta:ons	of	autosomal	
recessive	polycys:c	kidney	disease	(ARPKD):	kidney-related	
and	non-kidney-related	phenotypes.	Pediatric	
Nephrology,	29(10),	1915–1925.	
h_ps://doi-org.ezproxy.o_erbein.edu/10.1007/
s00467-013-2634-1	
Po_s,	J.	W.,	&	Mousa,	S.	A.	(2017).	Recent	advances	in	
management	of	autosomal-dominant	polycys:c	kidney	
disease.	American	Journal	of	Health-System	Pharmacy,	74(23),	
1959–1968.	
h_ps://doi-org.ezproxy.o_erbein.edu/10.2146/ajhp160886	
Silverman,	J.,	Desai,	C.,	&	Lerma,	E.	V.	(2015).	Autosomal	
dominant	polycys:c	kidney	disease.	Disease	a	Month,	61(10),	
442.	Retrieved	from	
h_ps://search-ebscohost-com.ezproxy.o_erbein.edu/
login.aspx?direct=true&db=edo&AN=110576122&site=eds-
live&scope=site	
Sweeney	Jr,	W.	E.,	Avner,	E.	D.,	&	Sweeney,	W.	E.,	Jr.	(2014).	
Pathophysiology	of	childhood	polycys:c	kidney	diseases:	new	
insights	into	disease-specific	therapy.	Pediatric	
Research,	75(1–2),	148–157.	
h_ps://doi-org.ezproxy.o_erbein.edu/10.1038/pr.2013.191	
Tran,	W.-C.,	Huynh,	D.,	Chan,	T.,	Chesla,	C.	A.,	&	Park,	M.	(2017).	
Understanding	barriers	to	medica:on,	dietary,	and	lifestyle	
treatments	prescribed	in	polycys:c	kidney	disease.	BMC	
Nephrology,	18(1),	214.	
h_ps://doi-org.ezproxy.o_erbein.edu/10.1186/
s12882-017-0641-3	
Gall,	E.	C.,	Alam,	A.,	&	Perrone,	R.	D.	(2019).	Autosomal	
dominant	polycys:c	kidney	disease.	The	
Lancet,	393(10174),	919-935.	doi:10.1016/
s0140-6736(18)32782-x	
	Paul,	B.	M.,	&	Heuvel,	G.	B.	(2014).	Kidney:	Polycys:c	kidney	
disease.	Wiley	Interdisciplinary	Reviews:	Developmental	
Biology,	3(6),	465-487.	doi:10.1002/wdev.152	
Sagar,	P.	S.,	Zhang,	J.,	Luciuk,	M.,	Mannix,	C.,	Wong,	A.	T.	Y.,	&	
Rangan,	G.	K.	(2019).	Increased	water	intake	reduces	long-
term	renal	and	cardiovascular	disease	progression	in	
experimental	polycys:c	kidney	disease.	PLoS	ONE,	14(01),	
1–18.	
h_ps://doi-org.ezproxy.o_erbein.edu/10.1371/
journal.pone.0209186	
Skorecki,	K.,	Chertow,	G.	M.,	Marsden,	P.	A.,	Taal,	M.	W.,	&	
Yu,	A.	S.	(2016).	Brenner	&	Rectors	the	kidney.	Philadelphia:	
Elsevier.	
Woon,	C.,	Bielinski-Bradbury,	A.,	O’Reilly,	K.,	&	Robinson,	P.	
(2015).	A	systema:c	review	of	the	predictors	of	disease	
progression	in	pa:ents	with	autosomal	dominant	
polycys:c	kidney	disease.	BMC	Nephrology,	16(1).	doi:
10.1186/s12882-015-0114-5	
